{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:14:41Z","timestamp":1790694881047,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013061","name":"Jilin Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["YDZJ202201ZYTS122"],"award-info":[{"award-number":["YDZJ202201ZYTS122"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>To investigate the usefulness of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-\u03b1), protein C\u00a0(PC), and thromboelastography (TEG) to serve as a predictor of portal vein thrombosis (PVT) in patients with liver cirrhosis. Additionally, we examined the clinical significance of the above indicators in terms of disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 123 patients with liver cirrhosis were recruited from May 2021 to December 2021, according to the imaging findings. They were divided into the PVT group (n\u2009=\u200952) and the non-PVT group (n\u2009=\u200971). Furthermore, patients with PVT were divided into plasma transfusion groups (n\u2009=\u200913) and non-plasma transfusion groups (n\u2009=\u200939). The basic general information, past medical history, laboratory, and imaging examination data were collected and analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In univariate analysis, there was no significant difference between the two groups in IL-6, PC, reaction time (R), alpha angle (Angle), maximum amplitude, or coagulation index (CI) (P\u2009&gt;\u20090.05). TNF-\u03b1 in the PVT group was significantly lower than that in the non-PVT group (P\u2009=\u20090.001). K-time (K) in the PVT group was significantly higher than that in the non-PVT group (P\u2009=\u20090.031). There was no significant difference in IL-6, TNF-\u03b1, PC, or TEG between different Child\u2013Pugh classification groups (P\u2009&gt;\u20090.05). There were no significant differences in TEG between the plasma transfusion group and the non-plasma transfusion group. In Binary logistic regression analysis, TNF-\u03b1 (OR\u2009=\u20090.9881, 95%CI\u2009=\u20090.971, 0.990, P\u2009&lt;\u20090.001), K(OR\u2009=\u20091.28, 95%\u2009=\u20091.053, 1.569, P\u2009=\u20090.014), activate partial thromboplastin time (APTT) (OR\u2009=\u20090.753, 95%CI\u2009=\u20090.656, 0.865, P\u2009&lt;\u20090.001), portal vein diameter (OR\u2009=\u20091.310, 95%CI\u2009=\u20091.108, 1.549, P\u2009=\u20090.002)and the history of splenectomy or embolism (OR\u2009=\u20097.565, 95%CI\u2009=\u20091.514, 37.799, P\u2009=\u20090.014)were related to the formation of PVT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TNF-\u03b1, K, APTT, portal vein diameter, and splenectomy or embolism history were associated with PVT formation, but IL-6 was not.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-022-02632-z","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T08:03:53Z","timestamp":1675065833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of related factors of portal vein thrombosis in liver cirrhosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaotong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"issue":"6","key":"2632_CR1","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/jgh.14501","volume":"34","author":"J Cool","year":"2019","unstructured":"Cool J, Rosenblatt R, Kumar S, et al. Portal vein thrombosis prevalence and associated mortality in cirrhosis in a nationally representative inpatient cohort [J]. J Gastroenterol Hepatol. 2019;34(6):1088\u201392. https:\/\/doi.org\/10.1111\/jgh.14501.","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"2632_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.tcm.2005.07.004","volume":"15","author":"M Levi","year":"2005","unstructured":"Levi M, van der Poll T. Two-way interactions between inflammation and coagulation [J]. Trends Cardiovasc Med. 2005;15(7):254\u20139. https:\/\/doi.org\/10.1016\/j.tcm.2005.07.004.","journal-title":"Trends Cardiovasc Med"},{"issue":"3","key":"2632_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/MEG.0000000000001526","volume":"32","author":"X Huang","year":"2020","unstructured":"Huang X, Fan X, Zhang R, et al. Systemic inflammation and portal vein thrombosis in cirrhotic patients with gastroesophageal varices [J]. Eur J Gastroenterol Hepatol. 2020;32(3):401\u20135. https:\/\/doi.org\/10.1097\/MEG.0000000000001526.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2632_CR4","doi-asserted-by":"publisher","first-page":"32188","DOI":"10.1038\/srep32188","volume":"6","author":"J Bester","year":"2016","unstructured":"Bester J, Pretorius E. Effects of il-1\u03b2, il-6 and il-8 on erythrocytes, platelets and clot viscoelasticity [J]. Sci Rep. 2016;6:32188. https:\/\/doi.org\/10.1038\/srep32188.","journal-title":"Sci Rep"},{"issue":"1","key":"2632_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jcp.21645","volume":"219","author":"IA Potapova","year":"2009","unstructured":"Potapova IA, Cohen IS, Doronin SV. Apoptotic endothelial cells demonstrate increased adhesiveness for human mesenchymal stem cells [J]. J Cell Physiol. 2009;219(1):23\u201330. https:\/\/doi.org\/10.1002\/jcp.21645.","journal-title":"J Cell Physiol"},{"issue":"8","key":"2632_CR6","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s11739-016-1416-8","volume":"11","author":"F Violi","year":"2016","unstructured":"Violi F, Corazza GR, Caldwell SH, et al. Portal vein thrombosis relevance on liver cirrhosis: Italian venous thrombotic events registry [J]. Intern Emerg Med. 2016;11(8):1059\u201366. https:\/\/doi.org\/10.1007\/s11739-016-1416-8.","journal-title":"Intern Emerg Med"},{"issue":"4","key":"2632_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jceh.2017.03.001","volume":"7","author":"V Somani","year":"2017","unstructured":"Somani V, Amarapurkar D, Shah A. Thromboelastography for assessing the risk of bleeding in patients with cirrhosis-moving closer [J]. J Clin Exp Hepatol. 2017;7(4):284\u20139. https:\/\/doi.org\/10.1016\/j.jceh.2017.03.001.","journal-title":"J Clin Exp Hepatol"},{"issue":"6","key":"2632_CR8","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/gutjnl-2020-322470","volume":"70","author":"JS Bajaj","year":"2021","unstructured":"Bajaj JS, Sikaroodi M, Shamsaddini A, et al. Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy [J]. Gut. 2021;70(6):1162\u201373. https:\/\/doi.org\/10.1136\/gutjnl-2020-322470.","journal-title":"Gut"},{"key":"2632_CR9","unstructured":"Chinese Society of Hepatology Chinese Medical Association. Chines guidelines on the management of liver cirrohosis [J]. Journal of Clinical Hepatology, 2019, 35(11)."},{"key":"2632_CR10","unstructured":"Hepatobiliary Disease Study Group Chinese Society of Gastroenterology Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai) [J]. J Clin Hepatol, 2020, 36(12): 2667\u20132673."},{"issue":"8","key":"2632_CR11","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/liv.14121","volume":"39","author":"C Noronha Ferreira","year":"2019","unstructured":"Noronha Ferreira C, Marinho RT, Cortez-Pinto H, et al. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: a prospective study [J]. Liver Int. 2019;39(8):1459\u201367. https:\/\/doi.org\/10.1111\/liv.14121.","journal-title":"Liver Int"},{"issue":"4","key":"2632_CR12","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.3892\/etm.2019.7300","volume":"17","author":"YF Cagin","year":"2019","unstructured":"Cagin YF, Bilgic Y, Berber I, et al. The risk factors of portal vein thrombosis in patients with liver cirrhosis [J]. Exp Ther Med. 2019;17(4):3189\u201394. https:\/\/doi.org\/10.3892\/etm.2019.7300.","journal-title":"Exp Ther Med"},{"key":"2632_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030800","author":"A Anton","year":"2022","unstructured":"Anton A, Campreci\u00f3s G, P\u00e9rez-Campuzano V, et al. The pathophysiology of portal vein thrombosis in cirrhosis: getting deeper into virchow\u2019s triad [J]. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11030800.","journal-title":"J Clin Med"},{"issue":"6","key":"2632_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","volume":"75","author":"F Turon","year":"2021","unstructured":"Turon F, Driever EG, Baiges A, et al. Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors [J]. J Hepatol. 2021;75(6):1367\u201376. https:\/\/doi.org\/10.1016\/j.jhep.2021.07.020.","journal-title":"J Hepatol"},{"issue":"2","key":"2632_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/meg.0000000000001774","volume":"32","author":"L Wang","year":"2021","unstructured":"Wang L, Guo X, Xu X, et al. Association of portal venous system thrombosis with endoscopic variceal treatment: a systematic review and meta-analysis [J]. Eur J Gastroenterol Hepatol. 2021;32(2):125\u201331. https:\/\/doi.org\/10.1097\/meg.0000000000001774.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2632_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9041181","author":"HC Hung","year":"2020","unstructured":"Hung HC, Lee JC, Cheng CH, et al. Protein s for portal vein thrombosis in cirrhotic patients waiting for liver transplantation [J]. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9041181.","journal-title":"J Clin Med"},{"issue":"1","key":"2632_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/MAJ.0b013e31826485fc","volume":"346","author":"X Qi","year":"2013","unstructured":"Qi X, Chen H, Han G. Effect of antithrombin, protein c and protein s on portal vein thrombosis in liver cirrhosis: a meta-analysis [J]. Am J Med Sci. 2013;346(1):38\u201344. https:\/\/doi.org\/10.1097\/MAJ.0b013e31826485fc.","journal-title":"Am J Med Sci"},{"issue":"1","key":"2632_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1440-1746.2009.05921.x","volume":"25","author":"D Zhang","year":"2010","unstructured":"Zhang D, Hao J, Yang N. Protein c and d-dimer are related to portal vein thrombosis in patients with liver cirrhosis [J]. J Gastroenterol Hepatol. 2010;25(1):116\u201321. https:\/\/doi.org\/10.1111\/j.1440-1746.2009.05921.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"2632_CR19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.intimp.2015.07.044","volume":"28","author":"A Saghazadeh","year":"2015","unstructured":"Saghazadeh A, Hafizi S, Rezaei N. Inflammation in venous thromboembolism: Cause or consequence? [J]. Int Immunopharmacol. 2015;28(1):655\u201365. https:\/\/doi.org\/10.1016\/j.intimp.2015.07.044.","journal-title":"Int Immunopharmacol"},{"key":"2632_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001982","author":"F Nery","year":"2020","unstructured":"Nery F, Carneiro P, Correia S, et al. Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study [J]. Eur J Gastroenterol Hepatol. 2020. https:\/\/doi.org\/10.1097\/MEG.0000000000001982.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2632_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fped.2018.00142","volume":"6","author":"BR Branchford","year":"2018","unstructured":"Branchford BR, Carpenter SL. The role of inflammation in venous thromboembolism [J]. Front Pediatr. 2018;6:142. https:\/\/doi.org\/10.3389\/fped.2018.00142.","journal-title":"Front Pediatr"},{"issue":"22","key":"2632_CR22","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","volume":"109","author":"M Levi","year":"2004","unstructured":"Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation [J]. Circulation. 2004;109(22):2698\u2013704. https:\/\/doi.org\/10.1161\/01.CIR.0000131660.51520.9A.","journal-title":"Circulation"},{"key":"2632_CR23","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.3389\/fimmu.2019.03150","volume":"10","author":"M Nosaka","year":"2019","unstructured":"Nosaka M, Ishida Y, Kimura A, et al. Crucial involvement of il-6 in thrombus resolution in mice via macrophage recruitment and the induction of proteolytic enzymes [J]. Front Immunol. 2019;10:3150. https:\/\/doi.org\/10.3389\/fimmu.2019.03150.","journal-title":"Front Immunol"},{"issue":"11","key":"2632_CR24","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1161\/ATVBAHA.118.311194","volume":"38","author":"M Nosaka","year":"2018","unstructured":"Nosaka M, Ishida Y, Kimura A, et al. Contribution of the tnf-\u03b1 (tumor necrosis factor-\u03b1)\u2013tnf-rp55 (tumor necrosis factor receptor p55) axis in the resolution of venous thrombus [J]. Arterioscler Thromb Vasc Biol. 2018;38(11):2638\u201350.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"2632_CR25","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1172\/jci19284","volume":"112","author":"B Cambien","year":"2003","unstructured":"Cambien B, Bergmeier W, Saffaripour S, et al. Antithrombotic activity of tnf-\u03b1 [J]. J Clin Investig. 2003;112(10):1589\u201396. https:\/\/doi.org\/10.1172\/jci19284.","journal-title":"J Clin Investig"},{"issue":"2","key":"2632_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.transci.2009.01.019","volume":"40","author":"H Reikvam","year":"2009","unstructured":"Reikvam H, Steien E, Hauge B, et al. Thrombelastography [J]. Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis. 2009;40(2):119\u201323. https:\/\/doi.org\/10.1016\/j.transci.2009.01.019.","journal-title":"Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis"},{"issue":"5","key":"2632_CR27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3109\/00365529609006772","volume":"31","author":"FY Lee","year":"1996","unstructured":"Lee FY, Lu RH, Tsai YT, et al. Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation [J]. Scand J Gastroenterol. 1996;31(5):500\u20135. https:\/\/doi.org\/10.3109\/00365529609006772.","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"2632_CR28","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1097\/00000542-200005000-00011","volume":"92","author":"V Camenzind","year":"2000","unstructured":"Camenzind V, Bombeli T, Seifert B, et al. Citrate storage affects thrombelastograph analysis [J]. Anesthesiology. 2000;92(5):1242\u20139. https:\/\/doi.org\/10.1097\/00000542-200005000-00011.","journal-title":"Anesthesiology"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02632-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02632-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02632-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T08:07:01Z","timestamp":1675066021000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02632-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2632"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02632-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1944547\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for the study was obtained from the Medical Ethics committee of The First Hospital of Jilin University (21K110-001). All study participants provided informed consent. And all methods were performed following the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}